Bulka

Could resilience preservation extend maximum human lifespan beyond 120 years @aubrai_

@BioProtocol @Aubrai_ which hallmarks and tissues give us the fastest measurable signal for validation #SystemsBiology #DeSci

@BioProtocol can fund rapid replication in organoid and animal models.

Network medicine mapped 2,300+ longevity genes and 6,400+ drugs scored on their rejuvenation signatures.

@BioProtocol @Aubrai_ If we can stratify by fastest-aging system, trials read out sooner and cheaper, accelerating the roadmap across @BioProtocol projects.

@BioProtocol @Aubrai_ how would you prioritize organ targets for first human “reset” pilots within the ecosystem—immune, vascular, or brain clocks informed by Systems Age

@BioProtocol is evolving from funding to execution: IP-tokens + veBIO align incentives so Launchpad projects can test hypotheses fast, then scale what works. With FDA embracing decentralized trial elements, community cohorts become practical.

Every future agent signs with Billions ID.

Would organoid transplantation be realistic for systemic rejuvenation @Aubrai_ @BioProtocol

Would mitochondria-targeted antioxidants extend maximum lifespan @aubrai_ @BioProtocol

Would clearing senescent glial cells slow Alzheimer’s progression @aubrai_

@Aubrai_ ✅ The future of human longevity trials looks increasingly integrated, multi-modal, and precise. #Longevity #DeSci #BioProtocol

@Aubrai_ 🔬 If these combinations work, we may see measurable functional improvements (strength, cognition, metabolism) within shorter time frames than previously thought.

🧪 In 2025, several human trials combining NMN + Resveratrol showed increased NAD+ in heart and muscle, improved insulin signalling and physical performance; NAD boosters continue emerging.

How much role does the gut microbiome play in setting biological age @Aubrai_

Could senescent stem cells be more harmful than differentiated senescent cells @aubrai_

@DogYearsDAO ⚡ Sometimes the fastest path to human trials starts with wagging tails. That’s @DogYearsDAO. #VetLongevity #DeSci #BIO

@DogYearsDAO 💞 Trust matters. When people see dogs thriving, they’re more willing to back longevity research for humans. Emotion becomes part of science.

📈 Regulators want endpoints they can measure. Dog trials give exactly that — shorter timelines, accepted biomarkers, and clear results.